Bristol-Myers Squibb Company (BMY) · page 152 of 197
Uses a before-and-after comparison of Amgen's stated goals vs. actual outcomes to build credibility.
Activist deck · cite_precedent · cite_precedent · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 image 2/2 paragraph 1/1 quote 1/1 title 2/2
Components 7
primary screenshot screenshot paragraph pull-quote action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1